1832 Asset Management L.P. Regeneron Pharmaceuticals, Inc. Transaction History

1832 Asset Management L.P.

$48.7 Billion
Q1 2025

A detailed history of 1832 Asset Management L.P. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, 1832 Asset Management L.P. holds 2,092 shares of REGN stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,092

Previous 4,787 56.3%

Holding current value

$1.06 Million

Previous $3.41 Million 61.1%

% of portfolio

0.0%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$634.14 - $744.83 $1.71 Million - $2.01 Million	-2,695 Reduced 56.3%	2,092 $1.33 Million
Q4 2024 Feb 14, 2025	BUY	$701.85 - $1046.91 $611,311 - $911,858	871 Added 22.24%	4,787 $3.41 Million
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $1.77 Million - $2.08 Million	1,731 Added 79.22%	3,916 $4.12 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $548,467 - $665,208	-621 Reduced 22.13%	2,185 $2.3 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $498,284 - $548,329	552 Added 24.49%	2,806 $2.7 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $273,638 - $311,240	353 Added 18.57%	2,254 $1.98 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $1.32 Million - $1.61 Million	1,901 New	1,901 $1.56 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $4.68 Million - $5.55 Million	-6,679 Reduced 75.1%	2,215 $1.59 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $4.02 Million - $4.89 Million	5,908 Added 197.86%	8,894 $7.31 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $460,946 - $500,452	-653 Reduced 17.94%	2,986 $2.15 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $370,210 - $467,186	-645 Reduced 15.06%	3,639 $2.51 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $515,449 - $694,509	940 Added 28.11%	4,284 $2.53 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $1.99 Million - $2.34 Million	3,344 New	3,344 $2.3 Million
Q4 2021 Feb 15, 2022	SELL	$543.48 - $670.97 $390,218 - $481,756	-718 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $412,153 - $488,929	718 New	718 $438,000
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $2.28 Million - $2.8 Million	-5,100 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $13.7 Million - $16.6 Million	-25,200 Reduced 83.17%	5,100 $2.95 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $14.9 Million - $19.5 Million	30,300 New	30,300 $18.7 Million
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $22,187 - $32,632	-66 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $1,198 - $1,659	-4 Reduced 5.71%	66 $21,000
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $335 - $403	-1 Reduced 1.41%	70 $26,000
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $3,160 - $3,676	9 Added 14.52%	71 $29,000
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $8,822 - $10,694	31 Added 100.0%	62 $23,000
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $9,790 - $12,207	31 New	31 $11,000

Others Institutions Holding REGN

# of Institutions

1,471

Shares Held

85.8M

Call Options Held

1.39M

Put Options Held

1.45M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $54.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.

Account

1832 Asset Management L.P. Regeneron Pharmaceuticals, Inc. Transaction History